Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 06/07/07
End: 12/30/07
Due: 12/30/08
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 04/01/22
Due: 04/01/23
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 06/30/15
Due: 06/30/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Safety and Tolerability Study of GB301 | NCT03865017 | VTBIO Co. LTD | user2@example.com | None | 2019-12-01 | 2021-12-01 | 2022-12-01 | - | - | 2025-07-14 |
| Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen | NCT03973099 | VTBIO Co. LTD | user2@example.com | None | 2007-06-07 | 2007-12-30 | 2008-12-30 | - | - | 2025-07-14 |
| A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease | NCT05016427 | VTBIO Co. LTD | user2@example.com | None | 2020-11-01 | 2022-04-01 | 2023-04-01 | - | - | 2025-07-14 |
| Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease | NCT01715350 | VTBIO Co. LTD | user2@example.com | None | 2012-05-31 | 2015-06-30 | 2016-06-30 | - | - | 2025-07-14 |